Charles Schwab Investment Management Inc Repligen Corp Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 377,900 shares of RGEN stock, worth $58.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
377,900
Previous 363,379
4.0%
Holding current value
$58.1 Million
Previous $54.1 Million
0.58%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding RGEN
# of Institutions
475Shares Held
54.8MCall Options Held
314KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.16 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$984 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$776 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$250 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$219 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.54B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....